SCHEMBL28291353

SCHEMBL28291353

CC(C)(C)N1CCC(=Cc2c(F)cc(C#N)cc2F)CC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 2/20 0.31
▸ CYP11B1 P15538 1/20 0.30
▸ CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20971867 0.77 GPR119 (0.48) —
SCHEMBL20897963 0.75 PRKACA (0.39) —
SCHEMBL20897942 0.75 PKM (0.32) —
Hydrochloric Acid SCHEMBL20897928 0.74 PRKACA (0.38) —
SCHEMBL28291346 0.68 MEN1 (0.33) —
SCHEMBL25133038 0.67 SLC6A9 (0.47) —
SCHEMBL28292803 0.66 SRD5A2 (0.36) —
SCHEMBL15536669 0.66 PROKR1 (0.32) —
SCHEMBL14808997 0.66 DRD3 (0.36) —
SCHEMBL28291347 0.64 SRD5A2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109661392-A For treating the mitochondrial inhibitors of proliferative disorder 巴斯利尔药物国际股份公司 2019-04-19 — — CN disclosed
Send feedback